Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
35,942
Sort by:
2019-2023 Diagnostic Imaging: A Market in Transition--X-ray, Ultrasound, MRI, CT, Nuclear Medicine, PET, PACS
US$ 3,850.00
This new worldwide strategic overview of the diagnostic imaging market includes the following:- Estimates of the market size and growth.- Sales forecasts by ... etc.- System service and support.- Internally developed and acquired diagnostic imaging and related technologies, including X-ray, ultrasound, MRI, CT, ...
January 2019
185 pages
Molecular Diagnostics: Market Research Report
US$ 5,600.00
This report analyzes the worldwide markets for Molecular Diagnostics in US$ Thousand by the following Applications: Infectious Disease Testing, Blood Screening, ... 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
December 2018
570 pages
2019-2023 Europe Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Market: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 19,700.00
... Current and Emerging Products Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. Review ... test. Strategic Recommendations New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation ...
December 2018
630 pages